跳至主要内容
临床试验/ITMCTR2024000158
ITMCTR2024000158已完成1 期

A clinical application study of metabolomics/miRNA in the treatment of IV stage Diabetic kidney disease patients with nourishing Yang and removing stasis method

Yirui Zhao0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 至 75(—)
性别
All

入选标准

  • (1) A definite history of diabetes;
  • (2) Ages between 40 and 75 years old, gender not specified;
  • (3) Blood pressure controlled within the range of 90-130mmHg/70-90mmHg;
  • (4) Meet the diagnostic criteria for type 2 diabetes in phase IV of the Chinese Medical Association Diabetes Branch's Guidelines for the Prevention and Treatment of Diabetes in China (2020);
  • (5) Inclusion of patients who meet the criteria for yang deficiency and blood stasis according to traditional Chinese medicine;
  • (6) Understand the entire process of the trial and voluntarily participate and sign the informed consent form.

排除标准

  • (1) Patients in stages I, II, III, and V of DKD;
  • (2) Patients diagnosed with type 1 diabetes or other types of diabetes;
  • (3) Primary renal diseases and other secondary renal diseases not caused by diabetes;
  • (4) Patients with diabetic ketoacidosis and urinary tract infections within the past month;
  • (5) Patients with other serious organic diseases (such as cardiovascular diseases, severe hematological diseases, tumors, etc.);
  • (6) Women during pregnancy or lactation;
  • (7) Patients with mental illness or non-compliance with instructions;
  • (8) Patients with a history of allergies or sensitivity to other drugs;
  • (9) Other patients participating in clinical trials of other drugs.

研究者

发起方
Yirui Zhao

相似试验

A clinical application study of metabolomics/miRNA... | 临床试验